| Literature DB >> 28004732 |
Reham Wasfi1, Walid F Elkhatib2,3, Hossam M Ashour4,5.
Abstract
Klebsiella pneumonia infection rates have increased dramatically. Molecular typing and virulence analysis are powerful tools that can shed light on Klebsiella pneumonia infections. Whereas 77.7% (28/36) of clinical isolates indicated multidrug resistant (MDR) patterns, 50% (18/36) indicated carpabenem resistance. Gene prevalence for the AcrAB efflux pump (82.14%) was more than that of the mdtK efflux pump (32.14%) in the MDR isolates. FimH-1 and mrkD genes were prevalent in wound and blood isolates. FimH-1 gene was prevalent in sputum while mrkD gene was prevalent in urine. Serum resistance associated with outer membrane protein coding gene (traT) was found in all blood isolates. IucC, entB, and Irp-1 were detected in 32.14%, 78.5% and 10.7% of MDR isolates, respectively. We used two Polymerase Chain Reaction (PCR) analyses: Enterobacterial Repetitive Intergenic Consensus (ERIC) and Random Amplified Polymorphic DNA (RAPD). ERIC-PCR revealed 21 and RAPD-PCR revealed 18 distinct patterns of isolates with similarity ≥80%. ERIC genotyping significantly correlated with resistance patterns and virulence determinants. RAPD genotyping significantly correlated with resistance patterns but not with virulence determinants. Both RAPD and ERIC genotyping methods had no correlation with the capsule types. These findings can help up better predict MDR Klebsiella pneumoniae outbreaks associated with specific genotyping patterns.Entities:
Mesh:
Substances:
Year: 2016 PMID: 28004732 PMCID: PMC5177892 DOI: 10.1038/srep38929
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
List of primers, expected amplicon size, and annealing temperatures.
| Gene | Primer Sequence (5′-----3′) | Amplicon size (bp) | Tm °C | Reference |
|---|---|---|---|---|
| For: ACTGGGCTACCTCTGCTTCARev: CTTGCATGAGCCATCTTTCA | 535 | 53 | Siu, | |
| For: GCCAACGTCTACGTTAACCTGRev: ATATTTCACGGTGCCTGAAAA | 180 | 43 | The current study | |
| For: CCACCAACTATTCCCTCGAARev: ATGGAACCCACATCGACATT | 226 | 43 | El Fertas-Aissani, | |
| For: TGGGGCAAAGAGGCGCTG GAGRev: CAGCCAGCGACACGGATTCTC | 636 | 51 | The current study | |
| For: CTGCTGGGAAAAGCGATTGTCRev: AAGGCGACTCAGGAGTGGCTT | 385 | 49 | The current study | |
| For: TGAATCGCGGGTGTCTTATGCRev: TCCCTCAATAAAGCCCACGCT | 238 | 49 | El Fertas-Aissani, | |
| For: GGTGTGGTGCGATGAGCACAGRev: CACGGTTCAGCCATCCCTGAG | 288 | 55 | El Fertas-Aissani, | |
| For: ATCAGCGGCCGGATTGGTAAARev: CGGGTTCGGGAAAATAGCGCG | 312 | 53 | The current study | |
| For: ATCAGCAACCCCGATCTGCGTRev: CCGGTGACTTGACGCAGTCCT | 527 | 51 | The current study | |
| For: GCGCTTAACTTCAGCTCARev: GATGATAAATCCACACCAGAA | 453 | 43 | The current study | |
| For: CTCCAGCTCTAACCGTAGCGRev: GGTCTGTACGTAGCCGATGG | 241 | 51 | The current study | |
| For: GAAATTTATAACAAAGACGGCRev: GACGTTACGTCGTATACTACG | 305 | 43 | The current study | |
| For: GGTGCTCTTTACATCATTGCRev: GCAATGGCCATTTGCGTTAG | 1283 | 47 | Fang, | |
| For: GGATTATGACAGCCTCTCCTRev: CGACTTGGTCCCAACAGTTT | 908 | 45 | Fang, |
Antimicrobial sensitivity patterns of multidrug resistant Klebsiella pneumoniae isolates and prevalence of genes coding for MDR efflux pumps (AcrAB & MdtK) and outer membrane porins (OmpK35 & OmpK36).
| Anti-biotype | Isolate No. | Antimicrobial resistance profile | Genes coding for porins and efflux pumps | ||||
|---|---|---|---|---|---|---|---|
| A1 | 1w | AMP-AMC-TZP-FOX-CAZ-CXM-AZM-IMP-ETP-AMK∆-CN-TOB-CIP-NA-C | + | + | + | + | + |
| A2 | 3 s | AMP-AMC- CAZ-CXM-AZM-TE-DOX∆-NA∆-SXT | − | − | − | + | + |
| A3 | 6w | AMP-AMC-TZP-FOX∆-CAZ-CXM-AZM-CN-TOB-CIP-NA∆-SXT- | + | + | − | + | + |
| A4 | 7 s | AMP-AMC-TZP-FOX-CAZ-CXM-AZM-IMP-ETP-CN-TOB | − | − | − | + | + |
| A5 | 8 s | AMP-CAZ-CXM-AZM-TOB-TE-SXT-C | − | + | − | + | + |
| A6 | 9 u | AMP-AMC-TZP-FOX-CAZ-CXM- IMP-ETP-AK-CN-TOB-CIP-NA | + | + | − | + | + |
| 21c | + | + | + | + | + | ||
| 26w | + | + | + | + | − | ||
| A7 | 10 u | AMP-AMC-TZP-FOX-CAZ-CXM-AZM-IMP-ETP-AK-TOB-CIP-NA-SXT-C∆ | + | + | + | + | + |
| A8 | 11 u | AMP-AMC-TZP-FOX-CAZ-CXM-AZM-IMP-ETP-AK-CN-TOB-TET-DOX-SXT-CIP-NA-C | − | + | + | + | + |
| 40b | + | − | − | + | + | ||
| 48b | − | + | − | + | + | ||
| A9 | 15 u | AMP-AMC-TZP-FOX-CAZ-CXM-AZM-IMP-ETP-AK-CN-TOB- SXT-CIP-NA-C | + | + | − | + | + |
| A10 | 18 u | AMP-AMC-CAZ-CXM-AZM- TET-DO-SXT- C | − | + | − | + | + |
| A11 | 20 s | AMP-AMC-TZP-FOX-CAZ-CXM-AZM-IMP-ETP-AK-CN-TOB- DO-SXT-CIP-NA-C | + | + | + | − | + |
| A12 | 28 s | AMP-AMC-TZP-FOX∆-CAZ-CXM-AZM-AK- ETP∆-TET-DO∆-SXT-CIP-NA | + | + | − | + | + |
| A13 | 33 u | AMP-AMC-TZP-FOX-CAZ-CXM-IMP-ETP-AK-CN-TOB- CIP-NA | + | + | − | − | + |
| A14 | 35b | AMP-AMC-TZP-FOX-CAZ-CXM-IMP-ETP-AK-CN-TOB- DO-TET∆-SXT-CIP-NA | + | + | + | + | + |
| A15 | 36 u | AMP-AMC-TZP- CAZ-CXM-AZM-CN-TOB-TET-AK-DO-SXT∆-CIP-NA | + | + | − | + | + |
| A16 | 41b | AMP-AMC-TZP-FOX-CAZ-CXM-IMP-ETP-AK- TOB-CIP∆ | + | − | − | + | + |
| A17 | 46w | AMP-AMC-CAZ-CXM- CN-TOB-TET-DOX∆-CIP∆- SXT | + | + | + | − | + |
| A18 | 47b | AMP-AMC-TZP-FOX-CAZ-CXM-AZM-IMP-ETP- AK∆-CN-TOB-TET-DO- CIP-NA-SXT∆ | + | + | + | + | + |
| A19 | 50 u | AMP-AMC-TZP-FOX-CAZ-CXM-AZM - CN- DO-SXT-CIP∆-NA | + | + | − | + | + |
| A20 | 51 u | AMP-AMC-TZP-FOX-CAZ-CXM-AZM-IMP-ETP-CN-TOB-AK∆-CIP-NA∆-SXT | + | − | − | + | + |
| A21 | 53 u | AMP-AMC-TZP∆-CXM∆-AZM∆- CN-TOB-TET-DO-SXT-CIP-NA-C | + | + | − | − | + |
| A22 | 56 u | AMP-AMC-TZP-FOX-CAZ-CXM-AZM-IMP-ETP-CN-TOB-AMK-TET-DO-CIP-NA-SXT | + | + | − | + | + |
| A23 | 57 u | AMP-AMC-TZP-FOX-CAZ-CXM-CN-TOB∆- TET-SXT-CIP-NA-C | + | + | − | + | + |
| A24 | 58 u | AMP-AMC-TZP-FOX-CAZ-CXM-AZM-SXT-NA∆- C | + | + | − | + | + |
Abbreviations: u: urine, w- wound, s: sputum, c: CSF, b: blood.
∆Intermediate sensitivity.
AMP: ampicillin; AMC: Amoxicillin/clavulanic acid; TZP: Piperacillin/tazobactam; CAZ: Ceftazidime; CXM: Cefuroxime; FOX: Cefoxitin; AZM: Azteronam; IMP: Imipenem; ETP: Ertapenem; AK: Amikacin; TET: Tetracycline; DO: Doxycycline; CN: Gentamicin; TOB: Tobramycin; CIP: Ciprofloxacin; NA: Nalidixic acid; SXT: Co-trimoxazole; C: Chloramphenicol.
Distribution of virulence genetic profiles of K. pneumoniae isolates among capsule genotypes.
| Isolate code* | Capsule serotype | Virulence genetic profile | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 1w | Non K1/K2 | + | + | + | + | + | + | + | V1 |
| 3s | K1 | − | + | + | + | − | + | − | V2 |
| 6w | K2 | − | + | + | − | + | − | + | V3 |
| 7s | Non K1/K2 | − | + | + | − | + | − | + | V4 |
| 8s | K1 | − | + | + | + | + | + | − | V5 |
| 10u | |||||||||
| 41b | |||||||||
| 48b | |||||||||
| 53u | |||||||||
| 9u | K2 | − | + | + | + | + | − | − | V6 |
| 11u | K1 | + | + | + | + | + | − | + | V7 |
| 15u | Non K1/K2 | − | + | + | − | + | − | − | V8 |
| 20s | |||||||||
| 46w | |||||||||
| 18u | Non K1/K2 | − | + | + | + | + | − | − | V9 |
| 26w | |||||||||
| 35b | |||||||||
| 56u | |||||||||
| 58u | |||||||||
| 21c | Non K1/K2 | + | + | + | + | + | − | − | V10 |
| 50u | |||||||||
| 57u | |||||||||
| 28s | Non K1/K2 | − | + | − | + | + | − | + | V11 |
| 33u | Non K1/K2 | − | − | + | + | − | − | − | V12 |
| 36u | Non K1/K2 | − | − | + | + | + | − | + | V13 |
| 40b | K1 | − | + | + | + | − | − | + | V14 |
| 47b | Non K1/K2 | − | + | + | + | + | + | + | V15 |
| 51u | Non K1/K2 | − | + | + | + | + | − | + | V16 |
Abbreviations: u: urine, w- wound, s: sputum, c: CSF, b: blood. Non K1/K2 = Non typable as K1 or K2 capsule genotypes.
Figure 1Dendrogram generated with Dice coefficient and the UPGMA clustering method, showing the genetic similarity among K. pneumoniae isolates by Enterobacterial Repetitive Intergenic Consensus (ERIC) genotyping.
Figure 2Dendrogram generated with Dice coefficient and the UPGMA clustering method, showing the genetic similarity among K. pneumoniae isolates by Random Amplified Polymorphic DNA (RAPD) genotyping.
Discriminatory potential of typing techniques for K. pneumoniae isolates.
| Isolate code | Antibiogram | Virulence gene pattern typing | Capsule serotyping | ERIC typing | RAPD typing |
|---|---|---|---|---|---|
| 1w | A1 | V1 | Non K1/K2 | E1 | R1 |
| 3s | A2 | V2 | K1 | E2 | R2 |
| 6w | A3 | V3 | K2 | E3 | R3a |
| 7s | A4 | V4 | Non K1/K2 | E4 | R4 |
| 8s | A5 | V5 | K1 | E5 | R5 |
| 9u | A6 | V6 | K2 | E6 | R6a |
| 10u | A7 | V5 | K1 | E7a | R7 |
| 11u | A8 | V7 | K1 | E8a | R8a |
| 15u | A9 | V8 | Non K1/K2 | E20 | R9 |
| 18u | A10 | V9 | Non K1/K2 | E9a | R6a |
| 20s | A11 | V8 | Non K1/K2 | E10 | R10 |
| 21c | A6 | V10 | Non K1/K2 | E9a | R10 |
| 26w | A6 | V9 | Non K1/K2 | E9b | R11 |
| 28s | A12 | V11 | Non K1/K2 | E13 | R3b |
| 33u | A13 | V12 | Non K1/K2 | E21 | R12 |
| 35b | A14 | V9 | Non K1/K2 | E13 | R13 |
| 36u | A15 | V13 | Non K1/K2 | E19 | R3d |
| 40b | A8 | V14 | Non K1/K2 | E11 | R14 |
| 41b | A16 | V5 | K1 | E14 | R15a |
| 46w | A17 | V8 | Non K1/K2 | E18 | R18 |
| 47b | A18 | V13 | Non K1/K2 | E7b | R17 |
| 48b | A8 | V5 | K1 | E15 | R15b |
| 50u | A19 | V10 | Non K1/K2 | E12 | R16 |
| 51u | A20 | V15 | Non K1/K2 | E13 | R3c |
| 53u | A21 | V5 | K1 | E17 | R6b |
| 56u | A22 | V9 | Non K1/K2 | E13 | R3d |
| 57u | A23 | V10 | Non K1/K2 | E8b | R8b |
| 58u | A24 | V9 | Non K1/K2 | E16 | R9 |
| Simpsons index of diversity | 0.984 | 0.925 | 0.519 | 0.969 | 0.955 |
Kendall’s tau-b correlation coefficient of Random Amplified Polymorphic DNA (RAPD) and Enterobacterial Repetitive Intergenic Consensus (ERIC) genotyping methods versus resistance patterns, virulence determinants, and capsule types of K. pneumoniae isolates.
| Genotyping method | Resistance pattern | Virulence determinant | Capsule type |
|---|---|---|---|
| RAPD | 0.306 | 0.268 ( | 0.106 ( |
| ERIC | 0. 520 | 0.352 | 0.210 ( |
*Correlation is significant at p < 0.05 (two-tailed).